CTLA4 and cervical cancer: As seen when analyzing the Treg frequency in tumors of cervical cancer, patients with high Treg frequency have significantly shorter OS than patients with low Treg frequency [20], indicating that an anti-CTLA-4 antibody could be a treatment target.